BLSH vs CRCL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BLSH

60.6
AI Score
VS
BLSH Wins

CRCL

56.7
AI Score

Investment Advisor Scores

BLSH

61score
Recommendation
HOLD

CRCL

57score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BLSH CRCL Winner
Forward P/E 37.037 47.8469 BLSH
PEG Ratio 0 6.8553 Tie
Revenue Growth 68.8% 16.9% BLSH
Earnings Growth 0.0% 32.1% CRCL
Tradestie Score 60.6/100 56.7/100 BLSH
Profit Margin 0.0% 15.3% CRCL
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CRCL

Relative Price Performance (Last 90 Days)

BLSH 1M: -22.5% · 3M: -3.4% CRCL 1M: -18.4% · 3M: -9.4%

Current Technical Phase

BLSH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $23.55

CRCL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 34

RSI (14): 34.0 · Price: $64.88

Fundamentals Snapshot

Metric BLSH CRCL
Market Cap — —
Forward P/E 7.8 51.9
Trailing P/E — 39.1
Revenue (TTM) — —
Revenue Growth 0.7% 0.2%
Gross Margin 1.0% 0.3%
Operating Margin -3.1% 0.2%
EPS -9.70 1.66
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BLSH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.